|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55 TWD | +0.36% |
|
+2.61% | -8.94% |
| Apr. 08 | Energenesis Biomedical CO.,LTD. announced a financing transaction | CI |
| Feb. 29 | Energenesis Biomedical CO.,LTD. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Energenesis Biomedical CO.,LTD. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 1.55 million compared to TWD 0.799 million a year ago. Net loss was TWD 56.34 million compared to TWD 30.63 million a year ago.
Basic loss per share from continuing operations was TWD 0.84 compared to TWD 0.46 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.94% | 128M | |
| +1.77% | 42.86B | |
| +45.38% | 41.36B | |
| +12.24% | 42.74B | |
| -8.83% | 27.68B | |
| +7.44% | 25.15B | |
| -23.01% | 18.63B | |
| +30.56% | 12.37B | |
| -1.82% | 11.92B | |
| +8.35% | 11.21B |
ENERGENESIS BIOMEDICAL CO.,LTD. 
